Investigational Drug Details
| Drug ID: | D299 |
| Drug Name: | Remogliflozin |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 136059718 |
| CasNo: | 329045-45-6 |
| Repositioning for NAFLD: | No |
| SMILES: | C(c1c(O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)nn(c1C)C(C)C)c1ccc(cc1)OC(C)C |
| Structure: |
|
| InChiKey: | GSINGUMRKGRYJP-VZWAGXQNSA-N |
| Molecular Weight: | 450.532 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 3 on-going (CTRI/2020/02/023250) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0706 | CTRI/2020/02/023250 | Phase 3 | Not Recruiting | No Results Available | 11/02/2020 | 24 November 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|